Access
To read this story in full you will need to login or make a payment (see right).
Correspondence
Nature 440, 278 (16 March 2006) | doi:10.1038/440278b; Published online 15 March 2006
Open Innovation Challenges
-
Efficient Chromosome Doubling: Plant Cell Division
The Seeker is looking for an efficient chromosome doubling method in plants and in particular, metho...
-
Fast Growth of Transformed Soybean Shoots
A method for accelerating growth of soybean shoots is desired.
- More Challenges
- Powered by:
nature jobs
Senior Scientist, Bioinformatics and Protein Design
- Novo Nordisk Foundation Center for Protein Research, University of Copenhagen
- Copenhagen 2200 Denmark
Post-doctoral Research in Super-Resolution imaging of Mitotic Processes.
- Samuel Lunenfeld Research Institute
- Toronto, ON Canada
Lyme vaccine demonized by advocacy groups
Edward McSweegan1
- 1692 Barrister Court, Crofton, Maryland 21114, USA
As a microbiologist who managed a federal programme on Lyme disease in the 1990s, I consider that any new clinical trials of a vaccine candidate based on the protein OspA, as mentioned in your News Feature "Uphill struggle" (Nature 439, 524–525; 2006), should be confined to Europe, for three reasons.First, Lyme disease is non-communicable, readily treatable with common antibiotics and geographically localized in the United States.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Engagement of CD47 Inhibits the Contact Hypersensitivity Response Via the Suppression of Motility and B7 Expression by Langerhans CellsJournal of Investigative Dermatology Original Article
